177 related articles for article (PubMed ID: 30033030)
1. Innate Immune Cells Are Regulated by Axl in Hypertensive Kidney.
Batchu SN; Dugbartey GJ; Wadosky KM; Mickelsen DM; Ko KA; Wood RW; Zhao Y; Yang X; Fowell DJ; Korshunov VA
Am J Pathol; 2018 Aug; 188(8):1794-1806. PubMed ID: 30033030
[TBL] [Abstract][Full Text] [Related]
2. Role of Axl in early kidney inflammation and progression of salt-dependent hypertension.
Batchu SN; Hughson A; Gerloff J; Fowell DJ; Korshunov VA
Hypertension; 2013 Aug; 62(2):302-9. PubMed ID: 23774230
[TBL] [Abstract][Full Text] [Related]
3. Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.
Batchu N; Hughson A; Wadosky KM; Morrell CN; Fowell DJ; Korshunov VA
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1638-1646. PubMed ID: 27365404
[TBL] [Abstract][Full Text] [Related]
4. Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis.
Zhen Y; Priest SO; Shao WH
J Immunol; 2016 Sep; 197(6):2187-94. PubMed ID: 27527599
[TBL] [Abstract][Full Text] [Related]
5. Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension.
Korshunov VA; Daul M; Massett MP; Berk BC
Hypertension; 2007 Dec; 50(6):1057-62. PubMed ID: 17923589
[TBL] [Abstract][Full Text] [Related]
6. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
Fiebeler A; Park JK; Muller DN; Lindschau C; Mengel M; Merkel S; Banas B; Luft FC; Haller H
Am J Kidney Dis; 2004 Feb; 43(2):286-95. PubMed ID: 14750094
[TBL] [Abstract][Full Text] [Related]
7. Axl is a key regulator of intestinal γδ T-cell homeostasis.
Kim SM; Park M; Yee SM; Ji KY; Lee EH; Nguyen TV; Nguyen TH; Jang J; Kim EM; Choi HR; Yun CH; Kang HS
FASEB J; 2019 Dec; 33(12):13386-13397. PubMed ID: 31550172
[TBL] [Abstract][Full Text] [Related]
8. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt.
Melaragno MG; Cavet ME; Yan C; Tai LK; Jin ZG; Haendeler J; Berk BC
J Mol Cell Cardiol; 2004 Oct; 37(4):881-7. PubMed ID: 15380678
[TBL] [Abstract][Full Text] [Related]
9. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
Hafizi S; Dahlbäck B
Cytokine Growth Factor Rev; 2006 Aug; 17(4):295-304. PubMed ID: 16737840
[TBL] [Abstract][Full Text] [Related]
10. AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.
Landolt L; Furriol J; Babickova J; Ahmed L; Eikrem Ø; Skogstrand T; Scherer A; Suliman S; Leh S; Lorens JB; Gausdal G; Marti HP; Osman T
Physiol Rep; 2019 May; 7(10):e14091. PubMed ID: 31134766
[TBL] [Abstract][Full Text] [Related]
11. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
12. NK cell development: gas matters.
Walzer T; Vivier E
Nat Immunol; 2006 Jul; 7(7):702-4. PubMed ID: 16785886
[No Abstract] [Full Text] [Related]
13. Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis.
Bauer T; Zagórska A; Jurkin J; Yasmin N; Köffel R; Richter S; Gesslbauer B; Lemke G; Strobl H
J Exp Med; 2012 Oct; 209(11):2033-47. PubMed ID: 23071254
[TBL] [Abstract][Full Text] [Related]
14. Axl tyrosine kinase protects against tubulo-interstitial apoptosis and progression of renal failure in a murine model of chronic kidney disease and hyperphosphataemia.
Hyde GD; Taylor RF; Ashton N; Borland SJ; Wu HS; Gilmore AP; Canfield AE
PLoS One; 2014; 9(7):e102096. PubMed ID: 25019319
[TBL] [Abstract][Full Text] [Related]
15. TAM receptors and the regulation of erythropoiesis in mice.
Tang H; Chen S; Wang H; Wu H; Lu Q; Han D
Haematologica; 2009 Mar; 94(3):326-34. PubMed ID: 19211638
[TBL] [Abstract][Full Text] [Related]
16. Axl signaling induces development of natural killer cells in vitro and in vivo.
Kim EM; Lee EH; Lee HY; Choi HR; Ji KY; Kim SM; Kim KD; Kang HS
Protoplasma; 2017 Mar; 254(2):1091-1101. PubMed ID: 27549806
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis.
Zhen Y; Lee IJ; Finkelman FD; Shao WH
J Autoimmun; 2018 Sep; 93():37-44. PubMed ID: 29895432
[TBL] [Abstract][Full Text] [Related]
18. The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology.
Yanagita M
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):465-70. PubMed ID: 15199298
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases.
Caraux A; Lu Q; Fernandez N; Riou S; Di Santo JP; Raulet DH; Lemke G; Roth C
Nat Immunol; 2006 Jul; 7(7):747-54. PubMed ID: 16751775
[TBL] [Abstract][Full Text] [Related]
20. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
Kirane A; Ludwig KF; Sorrelle N; Haaland G; Sandal T; Ranaweera R; Toombs JE; Wang M; Dineen SP; Micklem D; Dellinger MT; Lorens JB; Brekken RA
Cancer Res; 2015 Sep; 75(18):3699-705. PubMed ID: 26206560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
